Open AccessAbstract CT189: Patient-specific dendritic cell vaccines with tumor antigens from self-renewing autologous tumor cells in the treatment of primary advanced ovarian cancer: A multi-institutional phase II clinical trial
Author(s) -
Lisa N. Abaid,
Bradley R. Corr,
James R. Mason,
Richard L. Friedman,
Ramez N. Eskander,
Candace Hsieh,
Chris J. Langford,
Krystal Carta,
Adrienne M. Wang,
James A. Langford,
Gabriel Nistor,
Robert O. Dillman
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct189
Subject(s) - medicine , leukapheresis , ovarian cancer , debulking , clinical endpoint , cancer , oncology , clinical trial , surgery , immunology , stem cell , biology , genetics , cd34